Profound Medical Corp.

TSX:PRN.TO

Medical - Devices

Healthcare
$9.83 +1.18%

+$0.11 today

Market cap
$360.04M
Beta
0.52
P/E (TTM)
-6.3
EPS (TTM)
-$1.07
52W Low $5.23High $12.40

Volume 0.00M

Average 0.01M

PRN.TO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Profound Medical Corp.TSX: PRN.TO

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q1 FY2026 weighted avg shares of 36.3M shares rose 20.8% year over year, behind the +21.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 18.1% from the prior quarter. Over 3 fiscal years it compounded at +13.3% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +20.8% toward the trailing-twelve-month pace of +21.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
36.3M+18.1% QoQ
Last fiscal yearDec 2025
30.23M+22.1% YoY
LTMMar 2026
31.8M+21.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+20.8%——
1 year+22.1%——
3-year CAGR+13.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
30.23M USD
Year-over-year change
+22.1%
4-year CAGR
+10.2%

Weighted Avg Shares vs competitors

How PRN.TO compares with its peers on the latest reported figures

  • PRN.TO's LTM Mar 2026 weighted avg shares of 31.8M shares is the 4th highest of the 6 companies compared; the peer median is 44.51M shares.
  • Its year-over-year change of +21.4% is the 2nd highest of 6, against a peer median of +2.7%.
  • Over three fiscal years its annual growth of +13.3% compares with a peer median of +9.6%.
PRN.TO Competitors Peer median
Weighted Avg Shares for PRN.TO and competitors
Company Period LTM YoY 3-year CAGR
XLY.TOAuxly Cannabis Group Inc.LTM Mar 20261.35B +5.3%+14.3%
CRRX.TOCareRx CorporationLTM Mar 202662.94M +2.7%+9.6%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 202644.51M +24.9%+27.5%
PRN.TOProfound Medical Corp.LTM Mar 202631.8M +21.4%+13.3%
HLS.TOHLS Therapeutics Inc.LTM Mar 202631.4M -0.7%-0.8%
DR.TOMedical Facilities CorporationLTM Mar 202618.7M -3.7%-12.8%
Peer median (excluding PRN.TO) 44.51M+2.7%+9.6%

Competitors are the stored peer set for PRN.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue6.87M6.68M7.2M10.68M16.38M
Cost of Revenue3.92M3.66M2.82M3.64M4.79M
Gross Profit2.95M3.02M4.38M7.04M11.59M
Gross Margin43.0%45.2%60.9%65.9%70.8%
Research & Development15.28M14.69M14.38M16.97M20.96M
Selling, General & Admin17.97M17.93M18.62M23.13M32.61M
Operating Expenses33.24M32.62M33M40.1M53.57M
Depreciation & Amortization1.88M1.6M929K936K569.8K
EBITDA(28.65M)(26.6M)(27M)(32.13M)(41.41M)
EBITDA Margin-416.8%-398.2%-375.0%-300.8%-252.8%
Operating Income(30.29M)(29.6M)(28.62M)(33.06M)(41.98M)
Operating Margin-440.7%-443.1%-397.5%-309.6%-256.3%
Interest Income205K1.06M1.64M1.44M1.09M
Interest Expense67K168.82K770K00
Other Income / Expenses(303K)1.22M200K5.24M(1.08M)
Income Before Tax(30.59M)(28.38M)(28.7M)(27.82M)(43.06M)
Pre-Tax Margin-445.1%-424.8%-398.6%-260.5%-262.9%
Income Tax Expense105K287K(128K)(2K)256.41K
Net Income(30.7M)(28.67M)(28.57M)(27.82M)(43.32M)
Net Margin-446.7%-429.1%-396.8%-260.4%-264.4%
EPS (Basic)(1.50)(1.38)(1.35)(1.12)(1.43)
EPS (Diluted)(1.50)(1.38)(1.35)(1.12)(1.43)
Weighted Avg Shares20.46M20.77M21.18M24.77M30.23M
Weighted Avg Shares (Diluted)20.47M20.77M21.18M24.77M30.23M

Profound Medical Corp.

TSX:PRN.TO

Intrinsic Alpha fair value

Locked

Current Price

$9.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.